April 29, 2020 / 4:50 PM / 3 months ago

BRIEF-Deinove FY Group Net Loss Widens To 10.2 Million Euros

April 29 (Reuters) - DEINOVE SA:

* GROUP NET LOSS FOR 2019 EUR 10.2 MILLION, COMPARED WITH LOSS OF EUR 8.7 MILLION IN 2018, MAINLY DUE TO PROGRESS OF DNV3837 CLINICAL PROGRAM

* CONSOLIDATED CASH POSITION EUR 3.0 MILLION AS OF MARCH 31, 2020

* END-DEC CONSOLIDATED OPERATING LOSS OF EUR 12.2 MILLION VERSUS LOSS OF EUR 10.5 MILLION YEAR AGO

* OBJECTIVES 2020: GENERATE REVENUES THROUGH COSMETICS BUSINESS, ADVANCE DNV3837 PR OGRAM TOWARDS PHASE III AND MONITOR EXPENSES TO MAINTAINFINANCIA L FLEXIBILITY

* INITIATION OF PHASE II TRIAL TESTING DNV3837 AS FIRST‐LINE TREAT MENT FOR SEVERE C. DIFFICILE GASTROINTESTINAL INFECTIONS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below